← brief for 2026-09-28 · Slowing decline

Natural product therapy in diabetic kidney disease: emerging multiomics-mediated signalling pathway and molecular target.

Key takeaways

This review looks at how natural products might help treat diabetic kidney disease. It discusses how these substances interact with the body's systems at a molecular level. This is a summary of research ideas and pathways, not a new clinical trial with patient results.

Who did this work

Wang KE (School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, No. 548 Binwen Road, Hangzhou, 310053, Zhejiang, China.) · Yu QQ (School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, No. 548 Binwen Road, Hangzhou, 310053, Zhejiang, China.) · Wang WF (School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, No. 548 Binwen Road, Hangzhou, 310053, Zhejiang, China.) · Wang YN (Department of Clinical Research, Xianyang Hospital of Yan'an University, No. 38, Middle Section, Wenlin Road, Xianyang, 712000, Shaanxi, China.) · Yang J (Department of Nephrology, The Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.) · Miao H (School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, No. 548 Binwen Road, Hangzhou, 310053, Zhejiang, China. [email protected].) · Liu LM (School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, No. 548 Binwen Road, Hangzhou, 310053, Zhejiang, China. [email protected].) · Zhao YY (School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, No. 548 Binwen Road, Hangzhou, 310053, Zhejiang, China. [email protected].)

Source

Paper · Europe PMC, CKD · 2026-09-23
https://doi.org/10.1186/s13020-026-01511-z